Navigation Links
Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
Date:8/14/2009

BEIJING, Aug. 14 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic China, today reported its financial results for the quarter and six months ended June 30, 2009.

    Second Quarter ("Q2") 2009 Highlights and Developments:

    -- Q2 diluted EPS of $0.10
    -- Q2 net income increased 120% to $4.8 million
    -- Q2 gross margin of 57.9% compared to 50.0% in Q2 of 2008
    -- Participated in the April 2009 61st PHARMCHINA in Zhengzhou, China, one
       of the largest exhibitions in Chinese pharmaceutical industry with a
       history of over 30 years, and entered sales agreements with five new
       distributors which the Company believes may increase the Company's
       market share
    -- Exhibited at the June 26-28 2009 International Conference for
       Bioeconomy/the 44th New Drugs Expo and increased its wholesale
       portfolio with three new drugs
    -- Started and completed building foundation of Inner Mongolia new
       facility, which the Company believes accounts for approximately 5% of
       the total build-out
    -- Awarded with Good Supply Practices Certification
    -- Two investors of preferred shares from the 2008 private placement
       financing opted to convert 172,413 shares of preferred stock to 172,413
       shares of common stock of the Company under Rule 144

Revenues for the second quarter of 2009 decreased 30% to $13.6 million from $19.4 million of the same period of 2008. Wholesale revenues, one of the revenue segments, accounting for 78% of total revenues, decreased 25% due to the Company's 2009 product pricing policy(1). Average unit wholesale selling price decreased 43% in the second quarter of 2009 over the same period of 2008, while 26% increase in wholes
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
2. Lotus Scarless Hair Transplantation (International) Medical Chain Institute Opens New Center on Beijings Prestigious ChangAn Avenue
3. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
4. NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
5. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
6. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
7. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
8. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
10. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... Frederick, MD (PRWEB) September 12, 2014 ... systems (LIMS), radio-frequency identification (RFID) solutions and sample ... version 5.1. , RURO completed work on the ... late August and it has already seen mass ... recent major release of version 5.0 brought an ...
(Date:9/11/2014)... team of Berkeley Lab researchers believes it has ... of single atomic layers of transition metal dichalcogenide ... promise for nanoelectronic and photonic applications. , ... of tungsten disulfide, one of the most promising ... existence of excitonic dark states energy states ...
(Date:9/11/2014)... surface of graphene, a one atom thick sheet of ... graphene oxide; a form of graphene that could have ... industries. Applied as paint, it could provide an ultra-strong, ... , Graphene oxide solutions can be used to ... even conventional bricks. After a simple chemical treatment, the ...
(Date:9/11/2014)... Sept. 11, 2014 XBiotech announced today it ... machine that the Company says will be used to ... system is designed to fill, stopper and crimp vials, ... Additionally, the unit is said to contain an in-line ... provide a high level of quality compared to less ...
Breaking Biology Technology:Limfinity® Version 5.1 Available 2Excitonic dark states shed light on TMDC atomic layers 2Excitonic dark states shed light on TMDC atomic layers 3Graphene paints a corrosion-free future 2
... Without effective and proper networking techniques, you may not be ... to other professionals. While people have their own networking style ... , ,You need to do what works best for you ... to learn new ideas about networking from other professionals who ...
... Neurognostics , a home-grown Milwaukee medical device company, finished ... first to take advantage of Wisconsin's new tax credits for ... an investment. , ,Neurognostics oversubscribed on its $1 million angel ... af Neurognostics. As a tech-based research and development company, the ...
... project to match genetic information from Alzheimer's patients with ... ,The two-year project is the first to tap the ... for its Personalized Medicine Research Project, one of the ... of electronic medical records, the project aims to develop ...
Cached Biology Technology:Improve your networking skills by learning from other professionals 2Improve your networking skills by learning from other professionals 3Improve your networking skills by learning from other professionals 4Milwaukee firm among first to use Act 255 tax credits in investor pitch 2Milwaukee firm among first to use Act 255 tax credits in investor pitch 3Milwaukee firm among first to use Act 255 tax credits in investor pitch 4Marshfield study mixes DNA into electronic medical record to screen for Alzheimer's 2Marshfield study mixes DNA into electronic medical record to screen for Alzheimer's 3
(Date:9/11/2014)... Rice Research Institute of Iran have discovered that ... Asia, has changed its host preferences in order to adjust ... adaptation for biological control of problematic weeds in rice fields ... have been described in the open access journal ... permixtana have been so far reported to feed ...
(Date:9/11/2014)... , Sept. 11, 2014 NXT-ID, Inc. (Nasdaq: ... the growing mobile commerce market, announced today that its shares ... commenced trading on The Nasdaq Capital Market. The common stock ... "NXTDW," respectively. As of today, the Company,s common stock will ... quoted on the OTCQB will now be traded on Nasdaq. ...
(Date:9/11/2014)... have long been fascinated by animals, ability to ... now, no studies have directly tested whether those ... of fighting than they would using the fighting ... of Montana recently discovered each species, weapons are ... of fighting., The groundbreaking research, conducted over the ...
Breaking Biology News(10 mins):Unusual host preference of a moth species could be useful for biological control 2UM research reveals secrets of animal weapons 2
... cure, is a common expression, but what happens if preventative ... women are going out of their way not to be ... recent paper by Larsson et al. in AIDS ... and cost-effectively prevented using a short course of antiretroviral therapy. ...
... Researchers from Stony Brook University Medical Center in New ... genuine ancient human species and not a descendant of healthy ... remains of a well-preserved female specimen, researchers determined the "hobbit" ... version of modern humans. Details of the study appear ...
... In an advance with overtones of Star Trek phasers and ... of an internal on-off "switch" that paralyzes animals when exposed ... even when the light is turned off. When exposed to ... study appears in the Journal of the American Chemical ...
Cached Biology News:'Hobbits' are a new human species -- according to the statistical analysis of fossils 2
... Zyagen tissue microarrays are derived from ... to rigorous quality control procedures to ensure ... are manually assembled in one block, sectioned ... mounted on coated slides. Sections are large ...
... Zyagen tissue microarrays are derived from frozen ... rigorous quality control procedures to ensure the ... manually assembled in one block, sectioned at ... coated slides. Sections are large (3-5mm in ...
... The DNA Engine Opticon real-time PCR detection ... for fluorescence excitation (450-495 nm) and a ... The Opticon system is built on an ... a thermal gradient feature. This item includes ...
... for Optimal Microdissection , CapSure HS and ... and rapid extraction of populations of pure ... with Laser Capture Microdissection., Ensure the ... Analysis , All CapSure LCM Caps have ...
Biology Products: